Coexpression cluster:C3184
From FANTOM5_SSTAR
Full id: C3184_Eosinophils_CD8_CD4_Neutrophils_hairy_Whole_B
Phase1 CAGE Peaks
Hg19::chr11:64107589..64107604,- | p@chr11:64107589..64107604 - |
Hg19::chr19:6772686..6772697,+ | p2@VAV1 |
Hg19::chr22:24823517..24823546,+ | p5@ADORA2A |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
5.91277682223884e-05 | 0.0374278772847718 | 2 | 220 | Signalling by NGF (Reactome):REACT_11061 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006909 | phagocytosis | 0.00025294983684129 |
GO:0010324 | membrane invagination | 0.00198514209351949 |
GO:0006897 | endocytosis | 0.00198514209351949 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 0.00247927857153759 |
GO:0016044 | membrane organization and biogenesis | 0.00247927857153759 |
GO:0001973 | adenosine receptor signaling pathway | 0.00299401826913486 |
GO:0001611 | A2A adenosine receptor activity, G-protein coupled | 0.00299401826913486 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 0.00349291848885374 |
GO:0042755 | eating behavior | 0.00349291848885374 |
GO:0051932 | synaptic transmission, GABAergic | 0.00349291848885374 |
GO:0001975 | response to amphetamine | 0.00349291848885374 |
GO:0014075 | response to amine stimulus | 0.00349291848885374 |
GO:0050790 | regulation of catalytic activity | 0.00366740246370577 |
GO:0016192 | vesicle-mediated transport | 0.00366740246370577 |
GO:0050806 | positive regulation of synaptic transmission | 0.00366740246370577 |
GO:0065009 | regulation of a molecular function | 0.00366740246370577 |
GO:0001609 | adenosine receptor activity, G-protein coupled | 0.00366740246370577 |
GO:0030676 | Rac guanyl-nucleotide exchange factor activity | 0.00366740246370577 |
GO:0051971 | positive regulation of transmission of nerve impulse | 0.00366740246370577 |
GO:0001963 | synaptic transmission, dopaminergic | 0.00366740246370577 |
GO:0031646 | positive regulation of neurological process | 0.00399167181551987 |
GO:0045785 | positive regulation of cell adhesion | 0.00714344921713767 |
GO:0050804 | regulation of synaptic transmission | 0.00728828147067584 |
GO:0051969 | regulation of transmission of nerve impulse | 0.00765586138917796 |
GO:0007270 | nerve-nerve synaptic transmission | 0.00765586138917796 |
GO:0006171 | cAMP biosynthetic process | 0.00765586138917796 |
GO:0046058 | cAMP metabolic process | 0.00851123181759712 |
GO:0007190 | adenylate cyclase activation | 0.00851123181759712 |
GO:0031644 | regulation of neurological process | 0.00851123181759712 |
GO:0045762 | positive regulation of adenylate cyclase activity | 0.00851123181759712 |
GO:0031281 | positive regulation of cyclase activity | 0.00851123181759712 |
GO:0051349 | positive regulation of lyase activity | 0.00851123181759712 |
GO:0007189 | G-protein signaling, adenylate cyclase activating pathway | 0.0109712805277906 |
GO:0007631 | feeding behavior | 0.0109712805277906 |
GO:0009190 | cyclic nucleotide biosynthetic process | 0.0109712805277906 |
GO:0045761 | regulation of adenylate cyclase activity | 0.0109712805277906 |
GO:0031279 | regulation of cyclase activity | 0.0109712805277906 |
GO:0051339 | regulation of lyase activity | 0.0109712805277906 |
GO:0045028 | purinergic nucleotide receptor activity, G-protein coupled | 0.0109712805277906 |
GO:0001608 | nucleotide receptor activity, G-protein coupled | 0.0109712805277906 |
GO:0016502 | nucleotide receptor activity | 0.0109712805277906 |
GO:0001614 | purinergic nucleotide receptor activity | 0.0109712805277906 |
GO:0009187 | cyclic nucleotide metabolic process | 0.0121763494559456 |
GO:0007242 | intracellular signaling cascade | 0.0135282592478952 |
GO:0019992 | diacylglycerol binding | 0.0137276904705138 |
GO:0010033 | response to organic substance | 0.0141114826117002 |
GO:0030155 | regulation of cell adhesion | 0.0147014195766507 |
GO:0006968 | cellular defense response | 0.0157024009538919 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.0175506373098121 |
GO:0007229 | integrin-mediated signaling pathway | 0.0175506373098121 |
GO:0019933 | cAMP-mediated signaling | 0.0175506373098121 |
GO:0007166 | cell surface receptor linked signal transduction | 0.0175506373098121 |
GO:0007596 | blood coagulation | 0.0197432993336674 |
GO:0050817 | coagulation | 0.019764653657151 |
GO:0007599 | hemostasis | 0.0199751569658774 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.0218567002300837 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 0.0223892589633975 |
GO:0050878 | regulation of body fluid levels | 0.0225433032418296 |
GO:0042060 | wound healing | 0.0232228968375412 |
GO:0005089 | Rho guanyl-nucleotide exchange factor activity | 0.0262997025568311 |
GO:0016043 | cellular component organization and biogenesis | 0.0262997025568311 |
GO:0008015 | blood circulation | 0.0262997025568311 |
GO:0003013 | circulatory system process | 0.0262997025568311 |
GO:0035023 | regulation of Rho protein signal transduction | 0.0262997025568311 |
GO:0005088 | Ras guanyl-nucleotide exchange factor activity | 0.0265368819590599 |
GO:0007626 | locomotory behavior | 0.0286623246375753 |
GO:0007266 | Rho protein signal transduction | 0.0293234423434123 |
GO:0043087 | regulation of GTPase activity | 0.0324158935762655 |
GO:0007417 | central nervous system development | 0.0355671701565904 |
GO:0006810 | transport | 0.0358650919401976 |
GO:0051234 | establishment of localization | 0.0366111125560204 |
GO:0009165 | nucleotide biosynthetic process | 0.0366111125560204 |
GO:0043085 | positive regulation of catalytic activity | 0.0366111125560204 |
GO:0019932 | second-messenger-mediated signaling | 0.0378026194446836 |
GO:0051239 | regulation of multicellular organismal process | 0.0385460220629078 |
GO:0007268 | synaptic transmission | 0.039193714268358 |
GO:0006954 | inflammatory response | 0.039193714268358 |
GO:0007610 | behavior | 0.039193714268358 |
GO:0051179 | localization | 0.039193714268358 |
GO:0051336 | regulation of hydrolase activity | 0.0397950531681832 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 0.0397950531681832 |
GO:0019226 | transmission of nerve impulse | 0.0419682489221858 |
GO:0009117 | nucleotide metabolic process | 0.0427127318453849 |
GO:0055086 | nucleobase, nucleoside and nucleotide metabolic process | 0.0455375661295008 |
GO:0046578 | regulation of Ras protein signal transduction | 0.0458554250684929 |
GO:0007165 | signal transduction | 0.0474101992469932 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
hematopoietic system | 6.60e-28 | 98 |
blood island | 6.60e-28 | 98 |
hemolymphoid system | 1.18e-24 | 108 |
immune system | 3.68e-15 | 93 |
connective tissue | 8.02e-14 | 371 |
blood | 9.07e-14 | 15 |
haemolymphatic fluid | 9.07e-14 | 15 |
organism substance | 9.07e-14 | 15 |
bone marrow | 8.24e-13 | 76 |
bone element | 4.80e-11 | 82 |
skeletal element | 4.19e-09 | 90 |
hemopoietic organ | 1.43e-08 | 7 |
immune organ | 1.43e-08 | 7 |
skeletal system | 3.48e-07 | 100 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 1.52e-10 | 10 |
hematologic cancer | 1.13e-09 | 51 |
immune system cancer | 1.13e-09 | 51 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.401049 |
MA0004.1 | 0.826076 |
MA0006.1 | 0.639288 |
MA0007.1 | 0.804807 |
MA0009.1 | 1.3275 |
MA0014.1 | 0.758317 |
MA0017.1 | 0.686276 |
MA0019.1 | 0.990656 |
MA0024.1 | 1.21731 |
MA0025.1 | 1.46617 |
MA0027.1 | 2.95767 |
MA0028.1 | 0.658629 |
MA0029.1 | 1.23771 |
MA0030.1 | 1.22561 |
MA0031.1 | 1.15713 |
MA0038.1 | 0.94098 |
MA0040.1 | 1.24388 |
MA0041.1 | 0.847069 |
MA0042.1 | 0.810843 |
MA0043.1 | 1.32783 |
MA0046.1 | 1.31611 |
MA0048.1 | 1.62115 |
MA0050.1 | 0.81185 |
MA0051.1 | 0.936307 |
MA0052.1 | 1.24796 |
MA0055.1 | 0.557638 |
MA0056.1 | 0 |
MA0057.1 | 1.59304 |
MA0058.1 | 0.716037 |
MA0059.1 | 0.714521 |
MA0060.1 | 0.492218 |
MA0061.1 | 1.15625 |
MA0063.1 | 0 |
MA0066.1 | 2.1667 |
MA0067.1 | 1.65513 |
MA0068.1 | 0.405474 |
MA0069.1 | 1.31207 |
MA0070.1 | 1.30033 |
MA0071.1 | 0.897953 |
MA0072.1 | 1.29561 |
MA0073.1 | 5.1975 |
MA0074.1 | 0.935474 |
MA0076.1 | 0.734647 |
MA0077.1 | 1.28751 |
MA0078.1 | 1.04495 |
MA0081.1 | 1.70054 |
MA0083.1 | 1.33535 |
MA0084.1 | 1.84562 |
MA0087.1 | 1.29304 |
MA0088.1 | 0.257905 |
MA0089.1 | 0 |
MA0090.1 | 0.751469 |
MA0091.1 | 0.829044 |
MA0092.1 | 0.785956 |
MA0093.1 | 1.55117 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.956299 |
MA0101.1 | 0.646932 |
MA0103.1 | 1.52002 |
MA0105.1 | 0.846801 |
MA0106.1 | 0.986396 |
MA0107.1 | 0.556367 |
MA0108.2 | 1.15387 |
MA0109.1 | 0 |
MA0111.1 | 0.767139 |
MA0113.1 | 1.00436 |
MA0114.1 | 0.549955 |
MA0115.1 | 1.57693 |
MA0116.1 | 0.560723 |
MA0117.1 | 1.36676 |
MA0119.1 | 0.695578 |
MA0122.1 | 1.39371 |
MA0124.1 | 1.53432 |
MA0125.1 | 1.44766 |
MA0130.1 | 0 |
MA0131.1 | 1.06461 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.35921 |
MA0136.1 | 0.948776 |
MA0139.1 | 0.440097 |
MA0140.1 | 0.894983 |
MA0141.1 | 0.712476 |
MA0142.1 | 1.12317 |
MA0143.1 | 1.00455 |
MA0144.1 | 0.531867 |
MA0145.1 | 0.273764 |
MA0146.1 | 0.707589 |
MA0147.1 | 0.565108 |
MA0148.1 | 0.854239 |
MA0149.1 | 0.884158 |
MA0062.2 | 0.449458 |
MA0035.2 | 0.894194 |
MA0039.2 | 0.757898 |
MA0138.2 | 1.04628 |
MA0002.2 | 1.20011 |
MA0137.2 | 0.666381 |
MA0104.2 | 0.491226 |
MA0047.2 | 0.973066 |
MA0112.2 | 3.77966 |
MA0065.2 | 1.39232 |
MA0150.1 | 0.744617 |
MA0151.1 | 0 |
MA0152.1 | 0.902317 |
MA0153.1 | 1.43021 |
MA0154.1 | 0.312019 |
MA0155.1 | 2.02721 |
MA0156.1 | 0.669101 |
MA0157.1 | 1.09377 |
MA0158.1 | 0 |
MA0159.1 | 0.565904 |
MA0160.1 | 0.871361 |
MA0161.1 | 0 |
MA0162.1 | 0.455568 |
MA0163.1 | 2.48891 |
MA0164.1 | 1.01792 |
MA0080.2 | 1.55139 |
MA0018.2 | 0.987913 |
MA0099.2 | 0.902716 |
MA0079.2 | 2.70224 |
MA0102.2 | 1.88331 |
MA0258.1 | 2.22591 |
MA0259.1 | 0.575594 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
EBF1#1879 | 3 | 8.906466846569 | 0.0014152328356098 | 0.0091260497726755 |
ELF1#1997 | 3 | 4.25809795880754 | 0.0129517987505461 | 0.0460265034437471 |
ZEB1#6935 | 2 | 11.2589546783626 | 0.0101022267664633 | 0.0377983900427277 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.